Copyright
©The Author(s) 2023.
World J Clin Cases. May 6, 2023; 11(13): 2890-2902
Published online May 6, 2023. doi: 10.12998/wjcc.v11.i13.2890
Published online May 6, 2023. doi: 10.12998/wjcc.v11.i13.2890
Figure 1 Individualised diabetes care - graphical abstract.
GLP-RA; SGLT2 inhibitor.
Figure 2 Vicious cycle of insulin resistance and weight gain.
Figure 3 Gut glucagon-like peptide, gastric inhibitory peptide and glucagon system and its pharmacological analogues.
GLP: Gut glucagon-like peptide; GIP: Gastric inhibitory peptide; GLP-1RA: Glucagon-like peptide-1 receptor agonist.
- Citation: Khor XY, Pappachan JM, Jeeyavudeen MS. Individualized diabetes care: Lessons from the real-world experience. World J Clin Cases 2023; 11(13): 2890-2902
- URL: https://www.wjgnet.com/2307-8960/full/v11/i13/2890.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i13.2890